GlassScriptPhysician profile
Eric Funwi Neba
NPI 1770193807
$2,664.68
in general payments reported to CMS, 2019-2025
14 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $320 · 2023: $463 · 2024: $419 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Travel and Lodging: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.85 |
| Travel and Lodging | $967.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,092.38 | 2025 | Neurostar Tms Therapy System |
| Alkermes, INC. | $369.97 | 2021-2024 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $236.08 | 2021-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $221.04 | 2021-2024 | Invega, Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $165.56 | 2022-2024 | Ingrezza |
| Abbvie INC. | $136.85 | 2021-2022 | |
| Lundbeck LLC | $99.29 | 2021-2023 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $95.65 | 2021-2024 | Trintellix |
| Axsome Therapeutics, INC. | $75.54 | 2023-2024 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $64.24 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $53.57 | 2024-2025 | Austedo Xr, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $18.49 | 2024 | Cobenfy |
| Vanda Pharmaceuticals INC. | $18.45 | 2025 | Fanapt, Hetlioz |
| Sunovion Pharmaceuticals INC. | $17.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Neba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.